AGP Limited (AGP): Result Preview – By Taurus Research
Aug 11 2025
Taurus Securities
- 2QCY25: – EPS: PKR 2.79, PAT: PKR 968Mn, up 1.5x over the SPLY.
- In 2QCY25, AGP’s topline is expected to clock-in at PKR 6.9Bn, up 20%YoY driven mainly by volumetric growth, the deregulation of non essential medicines and higher prices for multiple essential medicines. However, on a quarterly basis, we expect sales to decline ~4%QoQ primarily due to seasonal effects that led to lower volumetric demand. Gross margins are expected to arrive ~57%, up 2pptYoY, mainly due to the higher drug prices. On a sequential basis, margins are likely to remain flat, as pricing gains are offset by lower sales volumes.
- Finance costs are expected to decline 52%YoY/7%QoQ on the back of lower interest rates. PAT to arrive at PKR 968Mn, up 1.5xYoY attributable to higher prices of medicines and decreased interest rate. Consequently, EPS is expected to clock-in at PKR 2.79/sh for the quarter. 1HCY25 PAT to arrive at PKR 1.6Bn, up 1.1xYoY.
Current:
Open:
Volume:
Change: ()
High:
Low:
52 Week High:
Vol Avg(12 m):
Free Float:
52 Week Low:
Market Cap:
Total Share:
Relative Strength Index (RSI)
RSI:
MACD Signals
MACD DAILY:
MACD WEEKLY:
Simple Moving Avg (SMA)
SMA(10):
SMA(30):
SMA(60):
SMA(200):
Performance
One Month:
Three Months:
Six Months:
Twelve Months:
Support & Resistance
Support 1:
Resistance 1:
Support 2:
Resistance 2:
High & Lows
Period
High
Low